Naloxone Market News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Naloxone market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Naloxone Market Today - Breaking & Trending Today

Global Naloxone (Parenteral, Intranasal, & Sublingual) Market Report 2021: Key Players are Hospira, Mylan, Kaleo, Amphastar Pharmaceuticals, Adapt Pharma, Mundipharma International


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global naloxone market held US$ 3,359.5 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 9.7% during the forecast period from 2021 to 2029.
Naloxone is an opioid antagonist designed to rapidly reverse opioid overdose. Naloxone is able to restore normal respiration of a person whose breathing has stopped or slowed down due to opioid or heroin overdose. Currently, opioid abuse is one of the foremost cause of drug overdose and leading cause of death globally. However, it is more common in North America and Europe.
The problem is paramount in the United States, where the mortality due to opioid overdose surged by 21% in 2016. The opioid crises in the U.S. is has reached epidemic phase, causing serious healthcare costs and losses to resources. The excessive need for better treatment and people suffering from opioid dependence is resulting in the growth in naloxone m ....

United States , Kern Pharma , Laura Wood , Office Hours Call , Amphastar Pharmaceuticals Inc , E St Office Hours Call , Therapeutics Inc , Indivior Plc , Pharma Inc , Kaleo Inc , Hospira Pfizer Inc , Mundipharma International , Market Size , Market Share , Application Analysis , Regional Outlook , Growth Trends , Key Players , Competitive Strategies , North America , Awareness Related , Opioid Overdose , Effective Treatment , Good Samaritan , America Dominated , Global Naloxone ,